A budding new approach strengthens an important message.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 37236153.
- Also identified by DOI 10.1016/j.cell.2023.04.034 and PMC identifier 10210232.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In vaccinology, both mRNA-based delivery of genes encoding antigens as well as nanoparticle-based vaccines have shown great promise in tackling challenging pathogens. In this issue of Cell, Hoffmann et al. combine these two approaches, harnessing the same cellular pathway hijacked by many viruses to boost immune responses to SARS-CoV-2 vaccination.
Medical subject headings
- COVID-19 Vaccines
- Nanoparticles